Preloading magnesium attenuates cisplatin-associated nephrotoxicity: pilot randomized controlled trial (PRAGMATIC study)

BACKGROUND: Cisplatin is one of the most potent chemotherapeutic drugs used in head and neck cancer treatment; however, nephrotoxicity is the major side-effect limiting usage. Magnesium supplementation has been reported to reduce risk in non-controlled studies. We investigated whether preloading wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Suppadungsuk, S., Phitakwatchara, W., Reungwetwattana, T., Pathumarak, A., Phakdeekitcharoen, B., Kitiyakara, C., Srisuwarn, P., Davenport, A., Nongnuch, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717436/
https://www.ncbi.nlm.nih.gov/pubmed/34953401
http://dx.doi.org/10.1016/j.esmoop.2021.100351

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8717436/
https://www.ncbi.nlm.nih.gov/pubmed/34953401
http://dx.doi.org/10.1016/j.esmoop.2021.100351

Ejemplares similares